$BIIB News Biogen Idec investors focu
Post# of 44845
Posted On: 02/04/2014 9:50:35 AM
$BIIB News
Biogen Idec investors focus on positive, ignore outlook for 2014
2:02 p.m. Jan. 29, 2014
- blogs.marketwatch.com
Biogen profit jumps on MS treatment revenue
7:09 a.m. Jan. 29, 2014
- MarketWatch.com
Stock investors trash market darlings, face Apple, Fed
8:00 a.m. Jan. 26, 2014
- Wallace Witkowski
The market puts a few feathers in its cap
1:58 p.m. Jan. 23, 2014
- The Trading Deck
Speculators turn the heat up to ‘soft boil’
3:54 p.m. Jan. 16, 2014
- The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales
4:22 p.m. Jan. 14, 2014
- Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper
4:17 p.m. Jan. 13, 2014
- Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies
9:38 a.m. Jan. 9, 2014
- MarketWatch.com
Earnings boost Micron, drag on Container Store
4:24 p.m. Jan. 8, 2014
- Ben Eisen
Goldman's biotech downgrade and the new consensus
11:53 a.m. Jan. 6, 2014
- MarketWatch.com
Charting a bullish year-end backdrop
12:28 p.m. Dec. 17, 2013
- Michael Ashbaugh
Charting a bullish year-end backdrop
12:03 p.m. Dec. 17, 2013
- Michael Ashbaugh
Get your portfolio to turn the corner
2:32 p.m. Dec. 10, 2013
- The Trading Deck
Speculators should retain a flexible approach
1:41 p.m. Dec. 4, 2013
- The Trading Deck
Growth stock players should reduce expectations
1:18 p.m. Nov. 26, 2013
- The Trading Deck
DaVita, Fresenius gain; energy firms slip
4:55 p.m. Nov. 25, 2013
- Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800
4:24 p.m. Nov. 22, 2013
- Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide
4:23 p.m. Nov. 22, 2013
- Ben Eisen
Biogen surges 13%, best on S&P 500
9:33 a.m. Nov. 22, 2013
- Laura Mandaro
The Four Horsemen send a message
12:46 p.m. Nov. 13, 2013
- The Trading Deck
Dear Healthcare Investors: The Correction, It's Here
5:16 a.m. Today5:16 a.m. Feb. 4, 2014
- Seeking Alpha
Guidance Update From Actavis - Analyst Blog
5:40 p.m. Feb. 3, 2014
- Zacks.com
Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard
5:01 p.m. Feb. 3, 2014
- TheStreet.com
Big Cap 20 Leaders Hang In There Despite Unsettled Market
4:52 p.m. Feb. 3, 2014
- Investors Business Daily
Biogen In Buy Range, Wins EU Approval For Tecfidera
3:34 p.m. Feb. 3, 2014
- Investors Business Daily
InterMune (ITMN) in Focus: Stock Tumbles 17.9% - Tale of the Tape
8:43 a.m. Feb. 3, 2014
- Zacks.com
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7:00 a.m. Feb. 3, 2014
- Zacks.com
China Biotech In Review: Mindray Acquires Control Of U.S.-China IVD Company
3:54 a.m. Feb. 2, 2014
- Seeking Alpha
Biotech Sector Performance January 2014 Strong, but What's Ailing Celgene?
2:12 p.m. Jan. 31, 2014
- TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape
9:30 a.m. Jan. 31, 2014
- Zacks.com
Facebook Tops 5 Leaders With Rising Profit Estimates
8:00 a.m. Jan. 31, 2014
- Investors Business Daily
Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains
7:22 a.m. Jan. 31, 2014
- 247WallSt.com
Biogen Idec Is a Buy Idea
12:09 a.m. Jan. 31, 2014
- Barrons.com
Celgene -2.2% after earnings, NEJM report, while other big biotechs surge
2:44 p.m. Jan. 30, 2014
- Seeking Alpha
FDA Nod for New Formulation of Teva's Copaxone - Analyst Blog
5:10 p.m. Jan. 29, 2014
- Zacks.com
Biogen's Report Sends Stock Up; Other Biotechs Follow
5:01 p.m. Jan. 29, 2014
- Investors Business Daily
Will Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog
4:30 p.m. Jan. 29, 2014
- Zacks.com
Biogen Beats, Tecfidera Continues to Shine - Analyst Blog
1:32 p.m. Jan. 29, 2014
- Zacks.com
Biogen MS Drug Tecfidera Outperforms; Outlook Light
10:41 a.m. Jan. 29, 2014
- Investors Business Daily
Facebook, Biogen, Sands Among Top Big Caps Reporting
7:02 a.m. Jan. 29, 2014
- Investors Business Daily
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director
8:00 a.m. Today8:00 a.m. Feb. 4, 2014
- PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in
the European Union as a First-Line Oral Treatment for Multiple Sclerosis
9:33 a.m. Feb. 3, 2014
- BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in
the European Union as a First-Line Oral Treatment for Multiple Sclerosis
8:53 a.m. Feb. 3, 2014
- BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine
8:40 a.m. Feb. 3, 2014
- BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel
7:00 a.m. Feb. 3, 2014
- BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to
Support Hall of Human Life
8:30 a.m. Jan. 30, 2014
- BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple
Sclerosis and Hemophilia Therapies in Asia
1:00 a.m. Jan. 30, 2014
- BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion
6:30 a.m. Jan. 29, 2014
- BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector
4:00 a.m. Jan. 27, 2014
- BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics
10:06 a.m. Jan. 24, 2014
- ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver
9:31 a.m. Jan. 24, 2014
- PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution
5:00 a.m. Jan. 20, 2014
- BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market
5:00 a.m. Jan. 16, 2014
- BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial
Results on January 29, 2014
4:01 p.m. Jan. 15, 2014
- BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at
Biotech Showcase
5:00 a.m. Jan. 15, 2014
- BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in
Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis
4:00 a.m. Jan. 15, 2014
- BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific
Officer Paul Stoffels with Lifetime Achievement Award at Annual
East/West CEO Conference
9:49 a.m. Jan. 14, 2014
- BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
9:10 a.m. Jan. 13, 2014
- PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology
5:53 a.m. Jan. 13, 2014
- BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies
7:10 a.m. Jan. 9, 2014
- PR Newswire
Biogen Idec investors focus on positive, ignore outlook for 2014
2:02 p.m. Jan. 29, 2014
- blogs.marketwatch.com
Biogen profit jumps on MS treatment revenue
7:09 a.m. Jan. 29, 2014
- MarketWatch.com
Stock investors trash market darlings, face Apple, Fed
8:00 a.m. Jan. 26, 2014
- Wallace Witkowski
The market puts a few feathers in its cap
1:58 p.m. Jan. 23, 2014
- The Trading Deck
Speculators turn the heat up to ‘soft boil’
3:54 p.m. Jan. 16, 2014
- The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales
4:22 p.m. Jan. 14, 2014
- Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper
4:17 p.m. Jan. 13, 2014
- Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies
9:38 a.m. Jan. 9, 2014
- MarketWatch.com
Earnings boost Micron, drag on Container Store
4:24 p.m. Jan. 8, 2014
- Ben Eisen
Goldman's biotech downgrade and the new consensus
11:53 a.m. Jan. 6, 2014
- MarketWatch.com
Charting a bullish year-end backdrop
12:28 p.m. Dec. 17, 2013
- Michael Ashbaugh
Charting a bullish year-end backdrop
12:03 p.m. Dec. 17, 2013
- Michael Ashbaugh
Get your portfolio to turn the corner
2:32 p.m. Dec. 10, 2013
- The Trading Deck
Speculators should retain a flexible approach
1:41 p.m. Dec. 4, 2013
- The Trading Deck
Growth stock players should reduce expectations
1:18 p.m. Nov. 26, 2013
- The Trading Deck
DaVita, Fresenius gain; energy firms slip
4:55 p.m. Nov. 25, 2013
- Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800
4:24 p.m. Nov. 22, 2013
- Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide
4:23 p.m. Nov. 22, 2013
- Ben Eisen
Biogen surges 13%, best on S&P 500
9:33 a.m. Nov. 22, 2013
- Laura Mandaro
The Four Horsemen send a message
12:46 p.m. Nov. 13, 2013
- The Trading Deck
Dear Healthcare Investors: The Correction, It's Here
5:16 a.m. Today5:16 a.m. Feb. 4, 2014
- Seeking Alpha
Guidance Update From Actavis - Analyst Blog
5:40 p.m. Feb. 3, 2014
- Zacks.com
Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard
5:01 p.m. Feb. 3, 2014
- TheStreet.com
Big Cap 20 Leaders Hang In There Despite Unsettled Market
4:52 p.m. Feb. 3, 2014
- Investors Business Daily
Biogen In Buy Range, Wins EU Approval For Tecfidera
3:34 p.m. Feb. 3, 2014
- Investors Business Daily
InterMune (ITMN) in Focus: Stock Tumbles 17.9% - Tale of the Tape
8:43 a.m. Feb. 3, 2014
- Zacks.com
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7:00 a.m. Feb. 3, 2014
- Zacks.com
China Biotech In Review: Mindray Acquires Control Of U.S.-China IVD Company
3:54 a.m. Feb. 2, 2014
- Seeking Alpha
Biotech Sector Performance January 2014 Strong, but What's Ailing Celgene?
2:12 p.m. Jan. 31, 2014
- TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape
9:30 a.m. Jan. 31, 2014
- Zacks.com
Facebook Tops 5 Leaders With Rising Profit Estimates
8:00 a.m. Jan. 31, 2014
- Investors Business Daily
Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains
7:22 a.m. Jan. 31, 2014
- 247WallSt.com
Biogen Idec Is a Buy Idea
12:09 a.m. Jan. 31, 2014
- Barrons.com
Celgene -2.2% after earnings, NEJM report, while other big biotechs surge
2:44 p.m. Jan. 30, 2014
- Seeking Alpha
FDA Nod for New Formulation of Teva's Copaxone - Analyst Blog
5:10 p.m. Jan. 29, 2014
- Zacks.com
Biogen's Report Sends Stock Up; Other Biotechs Follow
5:01 p.m. Jan. 29, 2014
- Investors Business Daily
Will Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog
4:30 p.m. Jan. 29, 2014
- Zacks.com
Biogen Beats, Tecfidera Continues to Shine - Analyst Blog
1:32 p.m. Jan. 29, 2014
- Zacks.com
Biogen MS Drug Tecfidera Outperforms; Outlook Light
10:41 a.m. Jan. 29, 2014
- Investors Business Daily
Facebook, Biogen, Sands Among Top Big Caps Reporting
7:02 a.m. Jan. 29, 2014
- Investors Business Daily
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director
8:00 a.m. Today8:00 a.m. Feb. 4, 2014
- PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in
the European Union as a First-Line Oral Treatment for Multiple Sclerosis
9:33 a.m. Feb. 3, 2014
- BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in
the European Union as a First-Line Oral Treatment for Multiple Sclerosis
8:53 a.m. Feb. 3, 2014
- BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine
8:40 a.m. Feb. 3, 2014
- BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel
7:00 a.m. Feb. 3, 2014
- BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to
Support Hall of Human Life
8:30 a.m. Jan. 30, 2014
- BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple
Sclerosis and Hemophilia Therapies in Asia
1:00 a.m. Jan. 30, 2014
- BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion
6:30 a.m. Jan. 29, 2014
- BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector
4:00 a.m. Jan. 27, 2014
- BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics
10:06 a.m. Jan. 24, 2014
- ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver
9:31 a.m. Jan. 24, 2014
- PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution
5:00 a.m. Jan. 20, 2014
- BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market
5:00 a.m. Jan. 16, 2014
- BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial
Results on January 29, 2014
4:01 p.m. Jan. 15, 2014
- BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at
Biotech Showcase
5:00 a.m. Jan. 15, 2014
- BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in
Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis
4:00 a.m. Jan. 15, 2014
- BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific
Officer Paul Stoffels with Lifetime Achievement Award at Annual
East/West CEO Conference
9:49 a.m. Jan. 14, 2014
- BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
9:10 a.m. Jan. 13, 2014
- PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology
5:53 a.m. Jan. 13, 2014
- BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies
7:10 a.m. Jan. 9, 2014
- PR Newswire
(0)
(0)Scroll down for more posts ▼